Cited by 126Cardiac Health and Mental HealthMental Health Treatment and AccessTreatment of Major Depression

The DOI matches its Crossref record; 128 of the 131 references it cites were found in a registry or an index.

Psychopharmacology and Cardiovascular Disease

Open access

Piña, Ileana L., Di Palo, Katherine E., Ventura, Hector O.·2018·Journal of the American College of Cardiology

DOI 10.1016/j.jacc.2018.03.458

Open this paper in CoChat — free account Open PDF

Abstract

This review discusses common mental health disorders and their associations with cardiovascular disease risks. Commonly found mental health disorders include depression, anxiety, and personality types. The link between depression and cardiovascular disease mortality has been established. Depression is also common in patients with heart failure. In addition to discussing psychological disorders, a review of psychotropic drugs is also included. Drugs are described for therapy for depression and anxiety, as well as associations with cardiovascular drug-drug interactions. Drug-drug interactions are more common and potentially dangerous in elderly patients, in whom the conditions often coexist. The most common drug-drug interactions involve the P450 system of enzymes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2018.03.458

Cites

128 of 128 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Forecasting the Future of Cardiovascular Disease in the United States: A Policy Statement From the American Heart Association
Heidenreich, P. A., Trogdon, J. G., Khavjou, O. A., Butler, J., Dracup, K., Ezekowitz, M. D., Finkelstein, E. A., Hong, Y., Johnston, S. C., Khera, A., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31820a55f5 · Cited by 3,208
Mortality in Mental Disorders and Global Disease Burden Implications: A Systematic Review and Meta-analysis
Walker, E. R., McGee, R. E., & Druss, B. G. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.2502 · Cited by 2,976
Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy.
Rozanski, A., Blumenthal, J. A., & Kaplan, J. (1999) · Circulation · doi:10.1161/01.cir.99.16.2192 · Cited by 2,846
Diet and Lifestyle Recommendations Revision 2006: A Scientific Statement From the American Heart Association Nutrition Committee
Lichtenstein, A. H., Appel, L. J., Brands, M., Carnethon, M., Daniels, S., Franch, H. A., Franklin, B., Kris-Etherton, P., Harris, W. S., Howard, B., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.176158 · Cited by 2,705
Association of psychosocial risk factors with risk of acute myocardial infarction in 11 119 cases and 13 648 controls from 52 countries (the INTERHEART study): case-control study
Rosengren, A., Hawken, S., Ôunpuu, S., Sliwa, K., Zubaid, M., Almahmeed, W. A., Blackett, K. N., Sitthi-amorn, C., Sato, H., & Yusuf, S. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17019-0 · Cited by 2,414
Depression Following Myocardial Infarction
Frasure‐Smith, N. (1993) · JAMA · doi:10.1001/jama.1993.03510150053029 · Cited by 2,039
Effects of Treating Depression and Low Perceived Social Support on Clinical Events After Myocardial Infarction: The Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial
(2003) · JAMA · doi:10.1001/jama.289.23.3106 · Cited by 1,870
Job decision latitude, job demands, and cardiovascular disease: a prospective study of Swedish men.
Karasek, R. A., Baker, D. B., Marxer, F., Ahlbom, A., & Theorell, T. (1981) · American Journal of Public Health · doi:10.2105/ajph.71.7.694 · Cited by 1,605
Depression and 18-Month Prognosis After Myocardial Infarction
Frasure‐Smith, N., Lespérance, F., & Talajic, M. R. (1995) · Circulation · doi:10.1161/01.cir.91.4.999 · Cited by 1,546
Depression in heart failure
Rutledge, T., Reis, V. A., Linke, S. E., Greenberg, B. H., & Mills, P. J. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.06.055 · Cited by 1,513
Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients
Nemeroff, C. B., Widerlöv, E., Bissette, G., Walléus, H., Karlsson, I., Eklund, K., Kilts, C. D., Loosen, P. T., & Vale, W. (1984) · Science · doi:10.1126/science.6334362 · Cited by 1,485
Depression and Coronary Heart Disease: Recommendations for Screening, Referral, and Treatment: A Science Advisory From the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: Endorsed by the American Psychiatric Association
Lichtman, J. H., Bigger, J. T., Blumenthal, J. A., Frasure-Smith, N., Kaufmann, P. G., Lespérance, F., Mark, D. B., Sheps, D. S., Taylor, C. B., & Froelicher, E. S. (2008) · Circulation · doi:10.1161/circulationaha.108.190769 · Cited by 1,482
Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis
Barth, J., Schumacher, M., & Herrmann-Lingen, C. (2004) · Psychosomatic Medicine · doi:10.1097/01.psy.0000146332.53619.b2 · Cited by 1,358
Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies
Nicholson, A., Kuper, H., & Hemingway, H. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl338 · Cited by 1,353
Social anxiety disorder
Stein, M. B., & Stein, D. J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60488-2 · Cited by 1,137
Depression as a predictor for coronary heart disease
Rugulies, R. (2002) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(02)00439-7 · Cited by 1,110
Untitled work
(2007) · PubMed · Cited by 953
Depression and the risk for cardiovascular diseases: Systematic review and meta analysis
Van der Kooy, K., van Hout, H., Marwijk, H., Marten, H., Stehouwer, C., & Beekman, A. (2007) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1723 · Cited by 951
Anxiety and Risk of Incident Coronary Heart Disease
Roest, A. M., Martens, E. J., de Jonge, P., & Denollet, J. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.03.034 · Cited by 865
Sudden Cardiac Death Triggered by an Earthquake
Leor, J., Poole, W. K., & Kloner, R. A. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602153340701 · Cited by 819
The Association of Anger and Hostility With Future Coronary Heart Disease
Chida, Y., & Steptoe, A. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.11.044 · Cited by 774
Five-Year Risk of Cardiac Mortality in Relation to Initial Severity and One-Year Changes in Depression Symptoms After Myocardial Infarction
Lespérance, F., Frasure‐Smith, N., Talajic, M. R., & Bourassa, M. G. (2002) · Circulation · doi:10.1161/hc0902.104707 · Cited by 722
Chronic psychosocial factors and acute physiological responses to laboratory-induced stress in healthy populations: a quantitative review of 30 years of investigations
Chida, Y., & Hamer, M. (2008) · Psychological Bulletin · doi:10.1037/a0013342 · Cited by 667
Depression as a risk factor for mortality after coronary artery bypass surgery
Blumenthal, J. A., Lett, H. S., Babyak, M. A., White, W., Smith, P. K., Mark, D. B., Jones, R., Mathew, J. P., & Newman, M. F. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14190-6 · Cited by 662
Guidelines for the Rational Use of Benzodiazepines: When and What to Use
Ashton, H. (1994) · Drugs · doi:10.2165/00003495-199448010-00004 · Cited by 593
Type A Behavior, Hostility, and Coronary Atherosclerosis*
Williams, R. B., Haney, T. L., Lee, K. L., Kong, Y., Blumenthal, J. A., & Whalen, R. E. (1980) · Psychosomatic Medicine · doi:10.1097/00006842-198011000-00002 · Cited by 592
Exaggerated platelet reactivity in major depression
Musselman, D. L., Tomer, A., Manatunga, A. K., Knight, B. T., Porter, M. R., Kasey, S., Marzec, U. M., Harker, L. A., & Nemeroff, C. B. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.10.1313 · Cited by 566
β-Blocker Therapy and Symptoms of Depression, Fatigue, and Sexual Dysfunction
Ko, D. T. (2002) · JAMA · doi:10.1001/jama.288.3.351 · Cited by 557
Effects of Psychological and Social Factors on Organic Disease: A Critical Assessment of Research on Coronary Heart Disease
Krantz, D. S., & McCeney, M. K. (2002) · Annual Review of Psychology · doi:10.1146/annurev.psych.53.100901.135208 · Cited by 484
Optimism, Cynical Hostility, and Incident Coronary Heart Disease and Mortality in the Women’s Health Initiative
Tindle, H. A., Chang, Y.-F., Kuller, L. H., Manson, J. E., Robinson, J. G., Rosal, M. C., Siegle, G. J., & Matthews, K. A. (2009) · Circulation · doi:10.1161/circulationaha.108.827642 · Cited by 483
Association of depression witk reduced heart rate variability in coronary artery disease
Carney, R. M., Saunders, R. D., Freedland, K. E., Stein, P. K., Rich, M. W., & Jaffe, A. S. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80155-6 · Cited by 482
The influence of age, gender, and race on the prevalence of depression in heart failure patients
Gottlieb, S. S., Khatta, M., Friedmann, E., Einbinder, L., Katzen, S. M., Baker, B., Marshall, J. P., Minshall, S., Robinson, S., Fisher, M. L., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.10.064 · Cited by 471
Prescribing Trends in Psychotropic Medications
Pincus, H. A., Tanielian, T., Marcus, S. C., Olfson, M., Zarin, D. A., Thompson, J., & ZITO, J. M. (1998) · JAMA · doi:10.1001/jama.279.7.526 · Cited by 423
Adverse drug events as a cause of hospital admission in the elderly
Chan, M., Nicklason, F., & Vial, J. H. (2001) · Internal Medicine Journal · doi:10.1046/j.1445-5994.2001.00044.x · Cited by 412
Inadequate Response to Treatment in Coronary Heart Disease
Denollet, J., Vaes, J., & Brutsaert, D. L. (2000) · Circulation · doi:10.1161/01.cir.102.6.630 · Cited by 388
Drug Interactions Due to Cytochrome P450
Ogu, C. C., & Maxa, J. L. (2000) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2000.11927719 · Cited by 370 · cited 1×
“There are at least 40 such enzymes, but 6 of them appear to be responsible for >90% of drug metabolism (122,123): CYP1A2, CYP2B6, CYP2C9, CYP2C19, CYP2D6, and CYP3A4.”
Background
Mental Stress—Induced Myocardial Ischemia and Cardiac Events
Jiang, W. (1996) · JAMA · doi:10.1001/jama.275.21.1651 · Cited by 358
Emotional and physical precipitants of ventricular arrhythmia
Lampert, R., Joska, T., Burg, M. M., Batsford, W. P., McPherson, C. A., & Jain, D. (2002) · Circulation · doi:10.1161/01.cir.0000031733.51374.c1 · Cited by 347
Effects of Mental Stress on Myocardial Ischemia During Daily Life
Gullette, E. C. D. (1997) · JAMA · doi:10.1001/jama.1997.03540430033029 · Cited by 346
Relationship of Depression to Death or Hospitalization in Patients With Heart Failure
Sherwood, A. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.4.367 · Cited by 336
Phobic Anxiety and Risk of Coronary Heart Disease and Sudden Cardiac Death Among Women
Albert, C. M., Chae, C. U., Rexrode, K. M., Manson, J. E., & Kawachi, I. I. (2005) · Circulation · doi:10.1161/01.cir.0000153813.64165.5d · Cited by 331
Work-Related Psychosocial Factors and the Development of Ischemic Heart Disease: A Systematic Review
Eller, N. H., Netterstrøm, B., Gyntelberg, F., Kristensen, T. S., Nielsen, F., Steptoe, A., & Theorell, T. (2009) · Cardiology in Review · doi:10.1097/crd.0b013e318198c8e9 · Cited by 323
The Pharmacologic Treatment of Anxiety Disorders: A Review of Progress
Ravindran, L. N., & Stein, M. B. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10r06218blu · Cited by 317
Effects of Exercise Training on Depressive Symptoms in Patients With Chronic Heart Failure: The HF-ACTION Randomized Trial
Blumenthal, J. A., Babyak, M. A., O’Connor, C., Keteyian, S., Landzberg, J., Howlett, J., Kraus, W., Gottlieb, S., Blackburn, G., Swank, A., et al. (2012) · JAMA · doi:10.1001/jama.2012.8720 · Cited by 305
A General Propensity to Psychological Distress Affects Cardiovascular Outcomes: Evidence From Research on the Type D (Distressed) Personality Profile
Denollet, J., Schiffer, A. A., & Spek, V. (2010) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.109.934406 · Cited by 282
Depression and vascular disease: what is the relationship?
Thomas, A. J. (2003) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00349-x · Cited by 267
Anxiety, Depression, and Cause-Specific Mortality: The HUNT Study
Mykletun, A., Bjerkeset, O. A., Dewey, M. E., Prince, M. J., Øverland, S. N., & Stewart, R. J. (2007) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31803cb862 · Cited by 265
Early-Onset Depression, Anxiety, and Risk of Subsequent Coronary Heart Disease
Janszky, I., Ahnve, S., Lundberg, I., & Hemmingsson, T. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.03.033 · Cited by 260
Efficacy and Safety of Fluoxetine in the Treatment of Patients With Major Depression After First Myocardial Infarction: Findings From a Double-Blind, Placebo-Controlled Trial
Strik, J. J. M. H., Honig, A., Lousberg, R. L., Lousberg, A., Cheriex, E. C., Tuynman-Qua, H. G., Kuijpers, P. M. J. C., Wellens, H. J. J., & van Praag, H. M. (2000) · Psychosomatic Medicine · doi:10.1097/00006842-200011000-00007 · Cited by 255
Meta-Analysis of Selective Serotonin Reuptake Inhibitor–Associated QTc Prolongation
Beach, S. R., Kostis, W. J., Celano, C. M., Januzzi, J. L., Ruskin, J. N., Noseworthy, P. A., & Huffman, J. C. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13r08672 · Cited by 253
Exaggerated Blood Pressure Responses During Mental Stress Are Associated With Enhanced Carotid Atherosclerosis in Middle-Aged Finnish Men
Kamarck, T. W., Everson‐Rose, S. A., Kaplan, G. A., Manuck, S. B., Jennings, J. R., Salonen, R. M., & Salonen, J. T. (1997) · Circulation · doi:10.1161/01.cir.96.11.3842 · Cited by 248
Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study
Tonstad, S. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00003-4 · Cited by 246
Pharmacologic treatment of anxiety disorders.
MAVISSAKALIAN, M. R. (1982) · PubMed · Cited by 243
Buspirone: What is it all about?
Loane, C., & Politis, M. (2012) · Brain Research · doi:10.1016/j.brainres.2012.04.032 · Cited by 223
Increased antidepressant use in patients prescribed beta-blockers
Avorn, J. (1986) · JAMA · doi:10.1001/jama.255.3.357 · Cited by 218
Increased incidence of life-threatening ventricular arrhythmias in implantable defibrillator patients after the World Trade Center attack
Steinberg, J. S., Arshad, A., Kowalski, M., Kukar, A., Suma, V. S., Vloka, M. E., EHLERT, F. A., Herweg, B., Donnelly, J., Philip, J., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.06.032 · Cited by 205
Propranolol-induced depression.
Waal, H. J. (1967) · BMJ · doi:10.1136/bmj.2.5543.50 · Cited by 205
Meta-Analysis of Selective Serotonin Reuptake Inhibitors in Patients With Depression and Coronary Heart Disease
Pizzi, C., Rutjes, A. W. S., Costa, G. M., Fontana, F., Mezzetti, A., & Manzoli, L. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.11.017 · Cited by 203
The Epidemiology of Serious Adverse Drug Reactions Among the Elderly
Atkin, P. A., Veitch, P. C., Veitch, E. M., & OGLE, S. J. (1999) · Drugs & Aging · doi:10.2165/00002512-199914020-00005 · Cited by 203
Meta-analyses of prospective studies on coronary heart disease, type A personality, and hostility
Myrtek, M. (2001) · International Journal of Cardiology · doi:10.1016/s0167-5273(01)00441-7 · Cited by 190
Depression in Patients Recovering From a Myocardial Infarction
Ziegelstein, R. C. (2001) · JAMA · doi:10.1001/jama.286.13.1621 · Cited by 187
Cardiac side effects of psychiatric drugs
Mackin, P. (2007) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.915 · Cited by 176
Triggers of myocardial ischemia during daily life in patients with coronary artery disease: Physical and mental activities, anger and smoking
Gabbay, F. H., Krantz, D. S., Kop, W. J., Hedges, S. M., Klein, J., Gottdiener, J. S., & Rozanski, A. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00510-2 · Cited by 175
Generalized Anxiety Disorder, Major Depressive Disorder, and Their Comorbidity as Predictors of All-Cause and Cardiovascular Mortality: The Vietnam Experience Study
Phillips, A. C., Batty, G. D., Galé, C. R., Deary, I. J., Osborn, D., Macintyre, K., & Carroll, D. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31819e6706 · Cited by 171
Cardiovascular effects of bupropion in depressed patients with heart disease
Roose, S. P., Dalack, G. W., Glassman, A. H., Woodring, S., Walsh, B. T., & Giardina, E. V. (1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.4.512 · Cited by 167
Treatment-Resistant Depression and Mortality After Acute Coronary Syndrome
Carney, R. M., & Freedland, K. E. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08081239 · Cited by 163 · cited 6×
“However, because selective serotonin reuptake inhibitors (SSRIs) are commonly used as antidepressants in patients with CAD, who are also likely to receive antiplatelet agents, the potential interaction of a serotonin transporter inhibitor with aspirin (ASA) and/or clopidogrel is worth noting (31–33).”
BackgroundInfluential
MENTAL STRESS AS A TRIGGER OF MYOCARDIAL ISCHEMIA AND INFARCTION**Preparation of this article was assisted by a grant from the NIH (HL47337) and USUHS grant RO7233. The opinions and assertions expressed herein are those of the authors and are not to be construed as reflecting the views of the USUHS or the US Department of Defense.
Krantz, D. S., Kop, W. J., Santiago, H. T., & Gottdiener, J. S. (1996) · Cardiology Clinics · doi:10.1016/s0733-8651(05)70280-0 · Cited by 159
Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction
Labos, C., Dasgupta, K., Nedjar, H., Turecki, G., & Rahme, E. (2011) · Canadian Medical Association Journal · doi:10.1503/cmaj.100912 · Cited by 159
Effects of Selective Serotonin Reuptake Inhibitor Therapy on Endothelial Function and Inflammatory Markers in Patients With Coronary Heart Disease
Pizzi, C., Mancini, S., Angeloni, L., Fontana, F., Manzoli, L., & Costa, G. M. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.121 · Cited by 148
Mental Health and Cardiovascular Disease
Chaddha, A., Robinson, E. A., Kline-Rogers, E. M., Alexandris-Souphis, T., & Rubenfire, M. (2016) · The American Journal of Medicine · doi:10.1016/j.amjmed.2016.05.018 · Cited by 148
Increased Antidepressant Use in Patients Prescribed β-Blockers
Avorn, J. (1986) · JAMA · doi:10.1001/jama.1986.03370030077031 · Cited by 147
Comorbid Depression and Anxiety Symptoms as Predictors of Cardiovascular Events: Results From the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study
Rutledge, T., Linke, S., Krantz, D. S., Johnson, B. D., Bittner, V., Eastwood, J., Eteiba, W., Pepine, C. J., Vaccarino, V., Francis, J., et al. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181bd6062 · Cited by 135
Relation of Depression to Severity of Illness in Heart Failure (from Heart Failure And a Controlled Trial Investigating Outcomes of Exercise Training [HF-ACTION])
Gottlieb, S. S., Kop, W. J., Ellis, S. J., Binkley, P., Howlett, J., O'Connor, C., Blumenthal, J. A., Fletcher, G., Swank, A. M., & Cooper, L. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.01.025 · Cited by 133
Increased prescribing of antidepressants subsequent to beta-blocker therapy
Thiessen, B. Q. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.150.11.2286 · Cited by 131
Social Anxiety Disorder
Schneier, F. R. (2006) · New England Journal of Medicine · doi:10.1056/nejmcp060145 · Cited by 130
INCREASE IN DEATHS FROM ISCHÆMIC HEART-DISEASE AFTER BLIZZARDS
Glass, R. I., & Zack, M. (1979) · The Lancet · doi:10.1016/s0140-6736(79)90835-3 · Cited by 114
Role of Exertion or Emotion as Inciting Events for Acute Aortic Dissection
Hatzaras, I. S., Bible, J. E., Koullias, G. J., Tranquilli, M., Singh, M., & Elefteriades, J. A. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.06.039 · Cited by 110
Correlation between the dexamethasone suppression test in depressed patients and clinical response
Nemeroff, C. B., & Evans, D. L. (1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.2.247 · Cited by 110
Understanding the pharmacokinetics of anxiolytic drugs
Altamura, A. C., Moliterno, D., Paletta, S., Maffini, M., Mauri, M. C., & Bareggi, S. R. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.759209 · Cited by 110
Depressive Symptoms and Outcomes in Patients with Heart Failure: Data from the COACH Study
Lesman‐Leegte, I., van Veldhuisen, D. J., Hillege, H. L., Moser, D. K., Sanderman, R., & Jaarsma, T. (2009) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfp155 · Cited by 108
Beta-blockers and depression. Evidence against an association
Bright, R. A. (1992) · JAMA · doi:10.1001/jama.267.13.1783 · Cited by 103
Depression and Congestive Heart Failure
Guck, T. P., Elsasser, G. N., Kavan, M., & J., E. J. E. (2003) · Congestive Heart Failure · doi:10.1111/j.1527-5299.2003.01356.x · Cited by 102
Safety and Efficacy of Sertraline for Depression in Patients with CHF (SADHART-CHF): A randomized, double-blind, placebo-controlled trial of sertraline for major depression with congestive heart failure
Jiang, W., O’Connor, C. M., Silva, S. G., Kuchibhatla, M. N., Cuffe, M. S., Callwood, D. D., Zakhary, B., Henke, E., Arias, R. M., & Krishnan, R. R. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.05.003 · Cited by 102
Use of selective serotonin reuptake inhibitors and risk of developing first‐time acute myocardial infarction
Meier, C. R., Schlienger, R. G., & Jick, H. (2001) · British Journal of Clinical Pharmacology · doi:10.1046/j.0306-5251.2001.01426.x · Cited by 101
Clinically Significant Psychotropic Drug-Drug Interactions in the Primary Care Setting
English, B. A., Dortch, M. J., Ereshefsky, L., & Jhee, S. S. (2012) · Current Psychiatry Reports · doi:10.1007/s11920-012-0284-9 · Cited by 101
Anxiety predicted premature all-cause and cardiovascular death in a 10-year follow-up of middle-aged women
Denollet, J., Maas, K., Knottnerus, J. A., Keyzer, J. J., & Pop, V. J. M. (2008) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2008.08.006 · Cited by 98
Increased Prescribing of Antidepressants Subsequent to ß-Blocker Therapy
Thiessen, B. Q. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.1990.00390220044009 · Cited by 95
Pharmacological treatment of generalized anxiety disorder
Reinhold, J. A., Mandos, L. A., Rickels, K., & Lohoff, F. W. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.618496 · Cited by 90
Cardiovascular Effects of Imipramine and Bupropion in Depressed Patients with Congestive Heart Failure
Roose, S. P., Glassman, A. H., Giardina, E. V., Johnson, L. L., Walsh, B. T., & Bigger, J. T. (1987) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198708000-00007 · Cited by 85
Reduction of platelet serotonin content in depressed patients treated with either paroxetine or desipramine
Javors, M. A., Houston, J. P., Tekell, J. L., Brannan, S. K., & Frazer, A. (2000) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114570000198x · Cited by 77
Is depression a major risk factor for coronary disease? A systematic review of the epidemiologic evidence
Wulsin, L. R. (2004) · Harvard Review of Psychiatry · doi:10.1080/10673220490447191 · Cited by 74
β-Blockers and Depression
Bright, R. A. (1992) · JAMA · doi:10.1001/jama.1992.03480130099032 · Cited by 72
Abnormal Platelet Aggregation Associated with Fluoxetine Therapy
Alderman, C., Moritz, C. K., & Ben-Tovim, D. I. (1992) · Annals of Pharmacotherapy · doi:10.1177/106002809202601205 · Cited by 68
Acute psychosocial stress and cardiovascular events
Stalnikowicz, R., & Tsafrir, A. (2002) · The American Journal of Emergency Medicine · doi:10.1053/ajem.2002.34788 · Cited by 62
Aspectos psiquiátricos y conductuales de la enfermedad cardiovascular: epidemiología, mecanismos y tratamiento
Smith, P. J., & Blumenthal, J. A. (2011) · Revista Española de Cardiología · doi:10.1016/j.recesp.2011.06.003 · Cited by 59
Prevalence of major depressive disorder in patients receiving beta-blocker therapy versus other medications
Carney, R. M., Rich, M. W., tevelde, A., Saini, J., Clark, K. A., & Freedland, K. E. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90689-9 · Cited by 54
Posttraumatic stress in implantable cardioverter defibrillator patients: The role of pre-implantation distress and shocks
Versteeg, H., Theuns, D. A. M. J., Erdman, R. A. M., Jordaens, L. J. L. M., & Pedersen, S. S. (2010) · International Journal of Cardiology · doi:10.1016/j.ijcard.2010.10.108 · Cited by 52
Phobic Anxiety and Increased Risk of Mortality in Coronary Heart Disease
Watkins, L. L., Blumenthal, J. A., Babyak, M. A., Davidson, J. R. T., McCants, C. B., O’Connor, C. J., & Sketch, M. H. (2010) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181e9f357 · Cited by 51
Cardiologic side effects of psychotropic drugs
Marano, G., Gianandrea, T., Romagnoli, E., Valeria, C., Lotrionte, M., Antonio, A., Biondi‐Zoccai, G., & Mazza, M. (2012) · 老年心脏病学杂志：英文版 · doi:10.3724/sp.j.1263.2011.00243 · Cited by 51
Digitalis and β-blocking agents: Effects on depression following myocardial infarction
Schleifer, S. J., Slater, W., Macari-Hinson, M. M., Coyle, D. A., Kahn, M., Zucker, H. D., & Gorlin, R. (1991) · American Heart Journal · doi:10.1016/0002-8703(91)90144-7 · Cited by 50
Is the Use of Psychotropic Drugs Associated with Increased Risk of Ischemic Heart Disease?
Lapane, K. L., Zierkr, S., Lasater, T. M., Barbour, M. M., Carleton, R. A., & Hume, A. L. (1995) · Epidemiology · doi:10.1097/00001648-199507000-00008 · Cited by 45
Antidepressive treatment as a modulator of inflammatory process in patients with heart failure: Effects on proinflammatory cytokines and acute phase protein levels
Tousoulis, D., Drolias, A., Antoniades, C. A., Vasiliadou, C., Marinou, K., Latsios, G., Stefanadi, E., Gounari, P., Siasos, G., Παπαγεωργίου, Ν., et al. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.02.013 · Cited by 44
Effect of imipramine and nortriptyline on left ventricular function and blood pressure in patients treated for arrhythmias
Giardina, E. V., Johnson, L. L., Vita, J. A., Bigger, J. T., & Brem, R. F. (1985) · American Heart Journal · doi:10.1016/0002-8703(85)90240-6 · Cited by 44
Psychiatric and Behavioral Aspects of Cardiovascular Disease: Epidemiology, Mechanisms, and Treatment
Smith, P. J., & Blumenthal, J. A. (2011) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2011.06.003 · Cited by 42
QT prolongation and polymorphous ventricular tachycardia associated with trasodone-amiodarone combination
Mazur, A., Strasberg, B., Kusniec, J., & Sclarovsky, S. (1995) · International Journal of Cardiology · doi:10.1016/0167-5273(95)02435-y · Cited by 35
Role of depression in heart failure — Choosing the right antidepressive treatment
Tousoulis, D., Antonopoulos, A. S., Antoniades, C. A., Saldari, C., Stefanadi, E., Siasos, G., Stougianos, P., Plastiras, A., Korompelis, P., & Stefanadis, C. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2009.05.022 · Cited by 34
The effect of antidepressant medications in the management of heart failure on outcomes: mortality, cardiovascular function and depression – a systematic review
Rajeswaran, T., Plymen, C. M., & Doherty, A. M. (2017) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651501.2017.1401085 · Cited by 32
Trazodone-Related Exercise-Induced Nonsustained Ventricular Tachycardia
Vitullo, R. N., Wharton, J. M., Allen, N. B., & Pritchett, E. L. C. (1990) · CHEST Journal · doi:10.1378/chest.98.1.247 · Cited by 30
Use of hypnotics and the risk of or mortality from heart disease: a meta-analysis of observational studies
Kim, Y.-H., Kim, H.-B., Kim, D.-H., Kim, J., & Shin, H. (2017) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2016.282 · Cited by 28
Associations of Job Strain and Occupation with Subclinical Atherosclerosis: The CARDIA Study
Greenlund, K. J., Kiefe, C. I., Giles, W. H., & Liu, K. (2010) · Annals of Epidemiology · doi:10.1016/j.annepidem.2010.02.007 · Cited by 27
Impact of metoprolol treatment on mental status of chronic heart failure patients with neuropsychiatric disorders
Liu, X., Lou, X., Cheng, X., & Meng, Y. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s124497 · Cited by 26
Adverse Cardiac Events in Older Patients Receiving Venlafaxine
Ho, J. M.-W., Gomes, T., Straus, S. E., Austin, P. C., Mamdani, M., & Juurlink, D. N. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08508 · Cited by 25
Effects of psychopharmacological treatment with antidepressants on the vascular system
Kahl, K. G., Westhoff‐Bleck, M., & Krüger, T. H. C. (2017) · Vascular Pharmacology · doi:10.1016/j.vph.2017.07.004 · Cited by 25
PROPRANOLOL AND DEPRESSION
Cremona-Barbaro, A. (1983) · The Lancet · doi:10.1016/s0140-6736(83)92786-1 · Cited by 24
Cardiovascular Effects of Psychotropic Drugs
Kovacs, D., & Arora, R. (2008) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e31802e4b9f · Cited by 23
Effect of atorvastatin and fluvastatin on the metabolism of midazolam by cytochrome P450 in vitro *
Donnell, C. G. M., Shorten, G. D., & Pelt, F. N. A. M. V. (2005) · Anaesthesia · doi:10.1111/j.1365-2044.2005.04110.x · Cited by 23
Generalised anxiety disorder
Scott, M. J. (2009) · Routledge eBooks · doi:10.4324/9780203879719-12 · Cited by 17
Heart and mind: (2) psychotropic and cardiovascular therapeutics
Shah, S. U., Iqbal, Z., White, A., & White, S. L. (2005) · Postgraduate Medical Journal · doi:10.1136/pgmj.2003.015230 · Cited by 17
The human coronary vasodilatory response to acute mental stress is mediated by neuronal nitric oxide synthase
Khan, S., Melikian, N., Shabeeh, H., Cabaco, A. R., Martin, K., Khan, F., O’Gallagher, K., Chowienczyk, P., & Shah, A. M. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00745.2016 · Cited by 15
Beta-blocker therapy is not associated with symptoms of depression and anxiety in patients receiving an implantable cardioverter-defibrillator
Hoogwegt, M. T., Kupper, N. H. M., Theuns, D. A. M. J., Jordaens, L. J. L. M., & Pedersen, S. S. (2011) · EP Europace · doi:10.1093/europace/eur295 · Cited by 13
The effects of imipramine, mianserin and trazodone on the chronotropic, inotropic and coronary vascular responses in the isolated perfused rat heart
Boschmans, S.-A., Perkin, M. F., Terblanche, S. E., & Opie, L. H. (1989) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(89)90022-0 · Cited by 12
Influence of diazepam and buspirone on human heart rate and the evoked cardiac response under varying cognitive load
Unrug, A., Bener, J., Barry, R. J., van Luijtelaar, E. L. J. M., Coenen, A. M. L., & Kaiser, J. (1997) · International Journal of Psychophysiology · doi:10.1016/s0167-8760(96)00744-1 · Cited by 11
Generalised anxiety disorder
Scott, M. J. (2012) · doi:10.4324/9780203808191-12 · Cited by 8
Effects of triazolam on heart rate level and on phasic cardiac response to noise during sleep
Libert, J., Amoros, C., Muzet, A. G., Ehrhart, J., & Nisi, J. D. (1988) · Psychopharmacology · doi:10.1007/bf00177559 · Cited by 7
Marital Stress Worsens Prognosis in Women With Coronary Heart Disease: The Stockholm Female Coronary Risk Study
Orth-Gomér, K., Wamala, S. P., Horsten, M., Schenck-Gustafsson, K., Schneiderman, N., & Mittleman, M. A. (2000) · JAMA · doi:10.1001/jama.284.23.3008 · Cited by 6
[PsyCoLaus: mental disorders and cardiovascular diseases: spurious association?].
Preisig, M., Waeber, G., Mooser, V., & Vollenweider, P. (2011) · PubMed · Cited by 5
Concomitant prescription of psychotropic and cardiovascular drugs in elderly patients
Ozturk, Z., & Turkyilmaz, A. (2017) · Psychiatry and Clinical Psychopharmacology · doi:10.1080/24750573.2017.1360829 · Cited by 5

Sorted by citations

Screening and Management of Depression in Patients With Cardiovascular Disease
Jha, M. K., Qamar, A., Vaduganathan, M., Charney, D. S., & Murrough, J. W. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.01.041 · Cited by 389
Severe Mental Illness and Cardiovascular Disease
Goldfarb, M., Binder, M. D., Detraux, J., Palo, K. E. D., Munir, H., Music, S., Piña, I. L., & Ringen, P. A. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.06.017 · Cited by 250
Self-citation
Depression and Heart Failure: The Lonely Comorbidity
Sbolli, M., Fiuzat, M., Cani, D., & O’Connor, C. M. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1865 · Cited by 255
2025 ESC Clinical Consensus Statement on mental health and cardiovascular disease: developed under the auspices of the ESC Clinical Practice Guidelines Committee
Bueno, H., Deaton, C., Farrero, M., Forsyth, F., Braunschweig, F., Buccheri, S., Dragan, S. R., Gevaert, S., Held, C., Kurpas, D., et al. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf191 · Cited by 224
Psychiatric and Psychological Interventions for Depression in Patients With Heart Disease: A Scoping Review
Zambrano, J., Celano, C. M., Januzzi, J. L., Massey, C. N., Chung, W., Millstein, R. A., & Huffman, J. C. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.018686 · Cited by 120

See all 126

Authors: Piña, I. L., Di Palo, K. E., & Ventura, H. O.
Affiliations: Albert Einstein College of Medicine (US)
Corresponding author: Piña, Ileana L.
ORCID: Piña, Ileana L.
Venue: Journal of the American College of Cardiology
Publisher: Elsevier BV
Published: 2018-05
Volume: 71
Issue: 20
Pages: 2346-2359
ISSN: 0735-1097 (ISSN-L)
DOI: 10.1016/j.jacc.2018.03.458
OpenAlex: W2803606348
Cited by: 126
References: 131
Citations by year: 2026: 9 · 2025: 14 · 2024: 20 · 2023: 20 · 2022: 23 · 2021: 13 · 2020: 11 · 2019: 11 · 2018: 5
FWCI: 1.87
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 386 d)
Locations: Journal of the American College of Cardiology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Keywords: psychopharmacology, cardiovascular disease, depression, anxiety, personality types, heart failure, cardiovascular mortality, psychotropic drugs, drug-drug interactions, elderly patients, cytochrome P450
MeSH terms: Mental Disorders, Cardiovascular Agents, Cardiovascular Diseases, Drug Interactions, Humans, Psychopharmacology, Psychotropic Drugs, Risk Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Psychopharmacology and Cardiovascular Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks